Batalini_&_Gulhan_et_al_CCR2022_Sig3_and_PARPi_response

Published: 17 August 2022| Version 1 | DOI: 10.17632/zg5xvm3f3w.1
Contributor:
Felipe Batalini

Description

Data referring to the cohorts used for analytical and clinical validation of Sig3 as biomarker for response to PARPi. Raw sequencing data deposited with dbGaP.

Files

Steps to reproduce

Detailed methods in the appropriate section at the CCR paper.

Institutions

Harvard Medical School

Categories

Clinical Research, Translational Oncology

License